Table 2.
COVID-19 history.
| Variable | N (%) |
|---|---|
| Time since COVID-19 Diagnosis | |
| 1–3 Months | 139 (42.0) |
| 3–6 Months | 74 (22.4) |
| ≥ 6 Months | 118 (35.6) |
| Symptoms during initial COVID-19 infection | |
| Fever | 252 (76.1) |
| Cough | 224 (67.7) |
| Body Aches | 215 (65.0) |
| Loss/Change in Sense of Smell | 164 (49.5) |
| Loss/Change in Sense of Taste | 146 (44.1) |
| Headache | 143 (43.2) |
| Loss of Appetite | 120 (36.3) |
| Nasal Stuffiness/Rhinorrhea | 117 (35.3) |
| Diarrhea | 87 (26.3) |
| Chest Discomfort/Pain | 79 (23.9) |
| Hair Fall | 74 (22.4) |
| Dyspnea | 61 (18.4) |
| Nausea/Vomiting | 59 (17.8) |
| Conjunctivitis | 21 (6.3) |
| Other Symptoms | 27 (8.2) |
| Asymptomatic | 17 (5.1) |
| Treatment/Management Received | |
| Anti-Pyretic | 283 (85.5) |
| Analgesics | 193 (58.3) |
| Antibiotics | 63 (19.0) |
| Steroids | 22 (6.6) |
| Multivitamins | 20 (6.0) |
| Ivermectin | 17 (5.1) |
| Anti-Allergy | 11 (3.3) |
| Remdesivir | 8 (2.4) |
| Non-Pharmacologic (Steam/Oral Fluids) | 13 (3.9) |
| No Treatment needed | 28 (8.5) |
| Residual Symptoms (Post-COVID-19) | |
| Body aches | 132 (39.9) |
| Low mood | 108 (32.6) |
| Cough | 100 (30.2) |
| Hair Fall | 78 (23.6) |
| Headache | 75 (22.7) |
| Loss of sense of smell | 57 (17.2) |
| Loss of sense of taste | 48 (14.5) |
| Loss of appetite | 43 (13.0) |
| Chest Discomfort/Pain | 42 (12.7) |
| Dyspnea | 30 (9.1) |
| Fever | 29 (8.8) |
| Nasal Stuffiness/Rhinorrhea | 28 (8.5) |
| Diarrhea | 27 (8.2) |
| Nausea/Vomiting | 16 (4.8) |
| Conjunctivitis | 2 (0.6) |
| Other Symptoms | 33 (10.0) |
| Asymptomatic | 54 (16.3) |